University of Texas Texas AM Investment Management Co. Acquires 46,141 Shares of CVS Health Corporation $CVS

University of Texas Texas AM Investment Management Co. raised its holdings in CVS Health Corporation (NYSE:CVS) by 7,527.1% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 46,754 shares of the pharmacy operator’s stock after acquiring an additional 46,141 shares during the period. University of Texas Texas AM Investment Management Co.’s holdings in CVS Health were worth $4,006,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Kilter Group LLC purchased a new position in shares of CVS Health during the second quarter worth about $27,000. J.Safra Asset Management Corp purchased a new stake in CVS Health in the second quarter valued at approximately $30,000. Beaird Harris Wealth Management LLC lifted its position in CVS Health by 201.0% during the second quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 195 shares during the last quarter. Timbuktu Capital Management LLC bought a new stake in CVS Health during the second quarter valued at approximately $31,000. Finally, Dunhill Financial LLC purchased a new position in CVS Health in the 2nd quarter worth approximately $32,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Stock Performance

NYSE:CVS opened at $83.76 on Monday. The business has a 50 day moving average of $90.37 and a 200 day moving average of $88.89. The company has a market capitalization of $107.17 billion, a price-to-earnings ratio of 9.75, a PEG ratio of 0.73 and a beta of 0.58. CVS Health Corporation has a 1-year low of $69.51 and a 1-year high of $110.68. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.66.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.65 by $0.44. CVS Health had a return on equity of 13.65% and a net margin of 2.62%. The business had revenue of $108.40 billion during the quarter, compared to analyst estimates of $104.72 billion. During the same quarter in the prior year, the firm earned $1.60 earnings per share. CVS Health’s revenue for the quarter was up 5.4% on a year-over-year basis. On average, sell-side analysts predict that CVS Health Corporation will post 8.25 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd were paid a $0.6650 dividend. The ex-dividend date of this dividend was Thursday, October 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.2%. CVS Health’s dividend payout ratio is 30.97%.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. Piper Sandler set a $112.00 price target on shares of CVS Health in a report on Wednesday, September 9th. Robert W. Baird set a $107.00 price objective on shares of CVS Health in a report on Thursday, August 6th. TD Cowen reaffirmed a “buy” rating on shares of CVS Health in a report on Wednesday. Wall Street Zen lowered shares of CVS Health from a “strong-buy” rating to a “buy” rating in a research report on Monday, October 19th. Finally, Truist Financial increased their target price on CVS Health from $108.00 to $118.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Twenty-two investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $108.25.

Key CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Executive Vice President Prem Shah bought 23,855 shares for about $2 million, increasing his direct stake by 36.9%. The sizable purchase may signal confidence in CVS’s prospects. SEC filing
• Positive Sentiment: CVS beat third-quarter earnings and revenue estimates and raised its 2026 outlook, with Aetna’s recovery among the factors supporting the improved outlook. Q3 earnings call coverage
• Neutral Sentiment: UBS lowered its price target to $107 but maintained a Buy rating, indicating continued optimism while reflecting a more cautious valuation. UBS rating
• Negative Sentiment: The planned separation of the retail pharmacy business from the insurance and pharmacy-benefit operations by 2028 has raised questions about execution, costs, and the value of the two businesses. The announcement overshadowed the earnings beat and was followed by a sharp selloff. Breakup and stock reaction
• Negative Sentiment: Additional concerns include weaker Medicare ratings and AM Best placing ratings for Aetna subsidiaries under review, creating uncertainty around the insurance business. Medicare ratings coverage

Insider Activity

In other CVS Health news, EVP Prem Shah bought 23,855 shares of CVS Health stock in a transaction that occurred on Friday, November 6th. The shares were bought at an average price of $83.89 per share, with a total value of $2,001,195.95. Following the acquisition, the executive vice president owned 88,516 shares in the company, valued at approximately $7,425,607.24. This trade represents a 36.89% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.85% of the company’s stock.

About CVS Health

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division.

The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.

Founded in 1963 as Consumer Value Stores in Lowell, Massachusetts, the company expanded from a retail pharmacy business into a broad health care organization and adopted the CVS Health name in 2014.